VEGFA and cancer: While promising as high-risk biomarkers, genes associated with the differentially methylated regions are enriched in processes such as EMT, VEGF and TGF-beta signaling, stemness, and cancer/metastasis signaling pathways, suggesting that these epigenetic changes functionally drive disease aggressiveness.